Lawrence Blonde, MD, FACP

Ochsner Medical Center
Critical Review of the Evidence Surrounding Differences in Current verses Emerging Insulins on: Glycemic Efficacy, Risk of Hypoglycemia, and Pharmacodynamics (absorption, variability)
Report 3: How Might SGLT-2s Be Used in Management of T2DM?
CMES206 An Investigative Symposium on Key Lipid and Glucose Challenges of Practice in T2DM